Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK) Stock Competitors & Peer Comparison
See (2607.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2607.HK | HK$11.92 | -1.16% | 69.6B | 6.26 | HK$1.92 | +4.47% |
| 1099.HK | HK$17.21 | -2.33% | 54B | 6.87 | HK$2.52 | +4.56% |
| 2192.HK | HK$7.50 | -0.66% | 5.5B | 15.10 | HK$0.50 | +3.87% |
| 2656.HK | HK$10.12 | +4.01% | 3.5B | -35.89 | -HK$0.28 | N/A |
| 2427.HK | HK$2.20 | +0.92% | 2.3B | -79.33 | -HK$0.03 | N/A |
| 2290.HK | HK$3.80 | +1.60% | 1.9B | 0.02 | HK$170.43 | N/A |
| 1931.HK | HK$0.65 | +1.56% | 1B | 3.27 | HK$0.20 | N/A |
| 2289.HK | HK$6.80 | -6.85% | 734.4M | 12.89 | HK$0.53 | +5.05% |
| 9955.HK | HK$0.51 | -1.92% | 335.8M | -0.95 | -HK$0.55 | N/A |
| 1298.HK | HK$1.10 | -8.33% | 303M | 80.59 | HK$0.01 | N/A |
Stock Comparison
2607.HK vs 1099.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 1099.HK has a market cap of 54B. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 1099.HK trades at HK$17.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 1099.HK's P/E ratio is 6.87. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 1099.HK's ROE of +0.09%. Regarding short-term risk, 2607.HK is less volatile compared to 1099.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 1099.HK's competition here
2607.HK vs 2192.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 2192.HK has a market cap of 5.5B. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 2192.HK trades at HK$7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 2192.HK's P/E ratio is 15.10. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 2192.HK's ROE of +0.07%. Regarding short-term risk, 2607.HK is more volatile compared to 2192.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.Check 2192.HK's competition here
2607.HK vs 2656.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 2656.HK has a market cap of 3.5B. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 2656.HK trades at HK$10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 2656.HK's P/E ratio is -35.89. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 2656.HK's ROE of N/A. Regarding short-term risk, 2607.HK is less volatile compared to 2656.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 2656.HK's competition here
2607.HK vs 2427.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 2427.HK has a market cap of 2.3B. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 2427.HK trades at HK$2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 2427.HK's P/E ratio is -79.33. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 2427.HK's ROE of N/A. Regarding short-term risk, 2607.HK is more volatile compared to 2427.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.Check 2427.HK's competition here
2607.HK vs 2290.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 2290.HK has a market cap of 1.9B. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 2290.HK trades at HK$3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 2290.HK's P/E ratio is 0.02. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 2290.HK's ROE of N/A. Regarding short-term risk, 2607.HK is less volatile compared to 2290.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 2290.HK's competition here
2607.HK vs 1931.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 1931.HK has a market cap of 1B. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 1931.HK trades at HK$0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 1931.HK's P/E ratio is 3.27. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 1931.HK's ROE of +0.01%. Regarding short-term risk, 2607.HK is more volatile compared to 1931.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.Check 1931.HK's competition here
2607.HK vs 2289.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 2289.HK has a market cap of 734.4M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 2289.HK trades at HK$6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 2289.HK's P/E ratio is 12.89. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 2289.HK's ROE of +0.08%. Regarding short-term risk, 2607.HK is more volatile compared to 2289.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.Check 2289.HK's competition here
2607.HK vs 9955.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 9955.HK has a market cap of 335.8M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 9955.HK trades at HK$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 9955.HK's P/E ratio is -0.95. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 9955.HK's ROE of -1.22%. Regarding short-term risk, 2607.HK is less volatile compared to 9955.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 9955.HK's competition here
2607.HK vs 1298.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 1298.HK has a market cap of 303M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 1298.HK trades at HK$1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 1298.HK's P/E ratio is 80.59. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 1298.HK's ROE of -0.01%. Regarding short-term risk, 2607.HK is more volatile compared to 1298.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.Check 1298.HK's competition here
2607.HK vs 0557.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 0557.HK has a market cap of 239.4M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 0557.HK trades at HK$0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 0557.HK's P/E ratio is -11.17. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 0557.HK's ROE of -0.19%. Regarding short-term risk, 2607.HK is less volatile compared to 0557.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 0557.HK's competition here
2607.HK vs 0673.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 0673.HK has a market cap of 172.6M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 0673.HK trades at HK$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 0673.HK's P/E ratio is -4.02. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 0673.HK's ROE of -2.73%. Regarding short-term risk, 2607.HK is less volatile compared to 0673.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 0673.HK's competition here
2607.HK vs 0718.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 0718.HK has a market cap of 168M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 0718.HK trades at HK$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 0718.HK's P/E ratio is -0.24. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 0718.HK's ROE of +0.22%. Regarding short-term risk, 2607.HK is less volatile compared to 0718.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 0718.HK's competition here
2607.HK vs 2393.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 2393.HK has a market cap of 123.6M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 2393.HK trades at HK$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 2393.HK's P/E ratio is -0.65. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 2393.HK's ROE of -0.18%. Regarding short-term risk, 2607.HK is less volatile compared to 2393.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 2393.HK's competition here
2607.HK vs 8372.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 8372.HK has a market cap of 106.4M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 8372.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 8372.HK's P/E ratio is 9.03. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 8372.HK's ROE of +0.09%. Regarding short-term risk, 2607.HK is less volatile compared to 8372.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.Check 8372.HK's competition here
2607.HK vs 0401.HK Comparison July 2026
2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2607.HK stands at 69.6B. In comparison, 0401.HK has a market cap of 66.7M. Regarding current trading prices, 2607.HK is priced at HK$11.92, while 0401.HK trades at HK$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2607.HK currently has a P/E ratio of 6.26, whereas 0401.HK's P/E ratio is -1.87. In terms of profitability, 2607.HK's ROE is +0.08%, compared to 0401.HK's ROE of -0.19%. Regarding short-term risk, 2607.HK is more volatile compared to 0401.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.Check 0401.HK's competition here